iShares Biotechnology ETF $IBB Stock: Lighthouse Financial LLC Raises Holdings

Lighthouse Financial LLC grew its position in iShares Biotechnology ETF (NASDAQ:IBB) by 89.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 17,966 shares of the financial services provider’s stock after acquiring an additional 8,496 shares during the period. iShares Biotechnology ETF comprises approximately 1.7% of Lighthouse Financial LLC’s investment portfolio, making the stock its 20th biggest position. Lighthouse Financial LLC’s holdings in iShares Biotechnology ETF were worth $3,782,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Wedbush Securities Inc. increased its stake in shares of iShares Biotechnology ETF by 20.1% in the 3rd quarter. Wedbush Securities Inc. now owns 5,086 shares of the financial services provider’s stock valued at $1,071,000 after purchasing an additional 851 shares in the last quarter. WASHINGTON TRUST Co acquired a new position in iShares Biotechnology ETF in the 3rd quarter worth about $211,000. Lake Street Private Wealth LLC purchased a new position in iShares Biotechnology ETF during the third quarter worth approximately $210,000. CMH Wealth Management LLC boosted its position in iShares Biotechnology ETF by 6.1% during the third quarter. CMH Wealth Management LLC now owns 30,583 shares of the financial services provider’s stock worth $6,439,000 after purchasing an additional 1,745 shares in the last quarter. Finally, Virtue Asset Management LLC boosted its position in iShares Biotechnology ETF by 78.5% during the third quarter. Virtue Asset Management LLC now owns 3,296 shares of the financial services provider’s stock worth $694,000 after purchasing an additional 1,450 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $207.74 on Friday. iShares Biotechnology ETF has a 12 month low of $154.62 and a 12 month high of $217.12. The stock’s 50 day moving average is $207.88 and its two-hundred day moving average is $189.30.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Tuesday, September 15th were given a dividend of $0.0112 per share. This is a negative change from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. The ex-dividend date was Tuesday, September 15th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.0%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.